Potential therapeutic applications of autophagy (original) (raw)

• Tallóczy, Z., Virgin, H. W. IV & Levine, B. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2, 24–29 (2006).
  Article PubMed Google Scholar
• Paludan, C. et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307, 593–596 (2005).
  Article CAS PubMed Google Scholar
• Rubinsztein, D. C. et al. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 1, 11–22 (2005).
  Article CAS PubMed Google Scholar
• Botti, J., Djavaheri-Mergny, M., Pilatte, Y. & Codogno, P. Autophagy signaling and the cogwheels of cancer. Autophagy 2, 67–73 (2006).
  Article CAS PubMed Google Scholar
• Jin, S. Autophagy, mitochondrial quality control, and oncogenesis. Autophagy 2, 80–84 (2006).
  Article CAS PubMed Google Scholar
• Kondo, Y. & Kondo, S. Autophagy and cancer therapy. Autophagy 2, 85–90 (2006).
  Article PubMed Google Scholar
• Levine, B. Unraveling the role of autophagy in cancer. Autophagy 2, 65–66 (2006).
  Article PubMed Google Scholar
• Belanger, M., Rodrigues, P. H., Dunn, W. A. Jr. & Progulske-Fox, A. Autophagy: a highway for Porphyromonas gingivalis in endothelial cells. Autophagy 2, 165–170 (2006).
  Article CAS PubMed Google Scholar
• Birmingham, C. L. & Brumell, J. H. Autophagy recognizes intracellular Salmonella enterica serovar Typhimurium in damaged vacuoles. Autophagy 2, 156–158 (2006).
  Article CAS PubMed Google Scholar
• Colombo, M. I., Gutierrez, M. G. & Romano, P. S. The two faces of autophagy: Coxiella and Mycobacterium. Autophagy 2, 162–164 (2006).
  Article CAS PubMed Google Scholar
• Dubuisson, J. F. & Swanson, M. S. Mouse infection by Legionella, a model to analyze autophagy. Autophagy 2, 179–182 (2006).
  Article CAS PubMed Google Scholar
• Ogawa, M. & Sasakawa, C. Shigella and autophagy. Autophagy 2, 171–174 (2006).
  Article CAS PubMed Google Scholar
• Vergne, I. et al. Autophagy in immune defense against Mycobacterium tuberculosis. Autophagy 2, 175–178 (2006).
  Article CAS PubMed Google Scholar
• Webster, P. Cytoplasmic bacteria and the autophagic pathway. Autophagy 2, 159–161 (2006).
  Article CAS PubMed Google Scholar
• Yoshimori, T. Autophagy vs. group A Streptococcus. Autophagy 2, 154–155 (2006).
  Article PubMed Google Scholar
• Klionsky, D. J. Autophagy (Landes Bioscience, Georgetown, 2004).
  Google Scholar
• Wang, C.-W. & Klionsky, D. J. The molecular mechanism of autophagy. Mol. Med. 9, 65–76 (2003).
  Article PubMed PubMed Central Google Scholar
• Massey, A. C., Zhang, C. & Cuervo, A. M. Chaperone-mediated autophagy in aging and disease. Curr. Top. Dev. Biol. 73, 205–235 (2006).
  Article CAS Google Scholar
• Yorimitsu, T. & Klionsky, D. J. Autophagy: molecular machinery for self-eating. Cell Death Differ. 12, 1542–1552 (2005).
  Article CAS PubMed Google Scholar
• Klionsky, D. J. et al. A unified nomenclature for yeast autophagy-related genes. Dev. Cell 5, 539–545 (2003).
  Article CAS PubMed Google Scholar
• Reggiori, F. & Klionsky, D. J. Autophagy in the eukaryotic cell. Eukaryot. Cell 1, 11–21 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ohsumi, Y. & Mizushima, N. Two ubiquitin-like conjugation systems essential for autophagy. Semin. Cell Dev. Biol. 15, 231–236 (2004).
  Article CAS PubMed Google Scholar
• Nair, U. & Klionsky, D. J. Molecular mechanisms and regulation of specific and nonspecific autophagy pathways in yeast. J. Biol. Chem. 280, 41785–41788 (2005).
  Article CAS PubMed Google Scholar
• Kihara, A., Kabeya, Y., Ohsumi, Y. & Yoshimori, T. Beclin-phosphatidylinositol 3-kinase complex functions at the _trans_-Golgi network. EMBO Rep. 2, 330–335 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Petiot, A., Ogier-Denis, E., Blommaart, E. F., Meijer, A. J. & Codogno, P. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 275, 992–998 (2000).
  Article CAS PubMed Google Scholar
• Kihara, A., Noda, T., Ishihara, N. & Ohsumi, Y. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol. 152, 519–530 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Liang, X. H. et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672–676 (1999). This paper demonstrates that BECN1 acts like the yeast ATG6 gene and promotes autophagy. The study also provides the first evidence that implicates BECN1 as a tumour-suppressor gene.
  Article CAS PubMed Google Scholar
• Qu, X. et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112, 1809–1820 (2003). This shows that the heterozygous inactivation of beclin1 results in tumour-predisposition in mice, which confirms that the loss of Beclin 1 activity (seen in certain human cancers) might be relevant to carcinogenesis.
  Article CAS PubMed PubMed Central Google Scholar
• Young, A. R. J. et al. Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J. Cell Sci. 119, 3888–3900 (2006).
  Article CAS PubMed Google Scholar
• Noda, T. et al. Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J. Cell Biol. 148, 465–480 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Blommaart, E. F., Luiken, J. J., Blommaart, P. J., van Woerkom, G. M. & Meijer, A. J. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270, 2320–2326 (1995).
  Article CAS PubMed Google Scholar
• Kamada, Y. et al. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J. Cell Biol. 150, 1507–1513 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Klionsky, D. J., Meijer, A. J., Codogno, P., Neufeld, T. P. & Scott, R. C. Autophagy and p70S6 kinase. Autophagy 1, 59–61 (2005).
  Article CAS PubMed Google Scholar
• Noda, T. & Ohsumi, Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273, 3963–3966 (1998).
  Article CAS PubMed Google Scholar
• Bjornsti, M. A. & Houghton, P. J. The TOR pathway: a target for cancer therapy. Nature Rev. Cancer 4, 335–348 (2004).
  Article CAS Google Scholar
• Galanis, E. et al. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J. Clin. Oncol. 23, 5294–5304 (2005).
  Article CAS PubMed Google Scholar
• Lee, V. W. & Chapman, J. R. Sirolimus: its role in nephrology. Nephrology (Carlton) 10, 606–614 (2005).
  Article CAS Google Scholar
• Frias, M. A. et al. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 16, 1865–1870 (2006).
  Article CAS PubMed Google Scholar
• Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098–1101 (2005).
  Article CAS PubMed Google Scholar
• Sarbassov, D. D. et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159–168 (2006).
  Article CAS PubMed Google Scholar
• Sabatini, D. M. mTOR and cancer: insights into a complex relationship. Nature Rev. Cancer 6, 729–34 (2006).
  Article CAS Google Scholar
• Sarkar, S. et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 170, 1101–1111 (2005). This paper describes a novel mTOR-independent pathway for inducing autophagy. This pathway, which is negatively regulated by IP 3 levels, can be activated by commonly used drugs such as lithium, carbemazepine and sodium valproate. Thus, these drugs might have clinical utility for autophagy upregulation.
  Article CAS PubMed PubMed Central Google Scholar
• Berridge, M. J. Unlocking the secrets of cell signaling. Annu. Rev. Physiol. 67, 1–21 (2005).
  Article CAS PubMed Google Scholar
• Menzies, F. M., Ravikumar, B. & Rubinsztein, D. C. Protective roles for induction of autophagy in multiple proteinopathies. Autophagy 2, 224–225 (2006).
  Article CAS PubMed Google Scholar
• Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805–810 (2004).
  Article CAS PubMed Google Scholar
• Sanchez, I., Mahlke, C. & Yuan, J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373–379 (2003).
  Article CAS PubMed Google Scholar
• Ravikumar, B., Duden, R. & Rubinsztein, D. C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11, 1107–1117 (2002). This was the first study that suggested that aggregate-prone intracytosolic proteins, such as mutant huntingtin fragments, are dependent on autophagy for their clearance. It also provides the 'proof-of-principle' for protective effects of autophagy upregulation in cell models of Huntington's disease.
  Article CAS PubMed Google Scholar
• Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N. & Rubinsztein, D. C. α-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009–25013 (2003).
  Article CAS PubMed Google Scholar
• Iwata, A. et al. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc. Natl Acad. Sci. USA 102, 13135–13140 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Qin, Z. H. et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum. Mol. Genet. 12, 3231–3244 (2003).
  Article CAS PubMed Google Scholar
• Shibata, M. et al. Regulation of intracellular accumulation of mutant huntingtin by Beclin 1. J. Biol. Chem. 281, 14474–14485 (2006).
  Article CAS PubMed Google Scholar
• Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature Genet. 36, 585–595 (2004). This study shows that rapamycin attenuates the toxicity of mutant huntingtin in vivo , using transgenic D. melangaster and mouse models. The study also reports upregulation of autophagy in polyglutamine diseases.
  Article CAS PubMed Google Scholar
• Berger, Z. et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15, 433–442 (2006).
  Article CAS PubMed Google Scholar
• Kabuta, T., Suzuki, Y. & Wada, K. Degradation of amyotrophic lateral sclerosis-linked mutant Cu, Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J. Biol. Chem. 281, 30524–30533 (2006).
  Article CAS PubMed Google Scholar
• Fortun, J., Dunn, W. A., Jr., Joy, S., Li, J. & Notterpek, L. Emerging role for autophagy in the removal of aggresomes in Schwann cells. J. Neurosci. 23, 10672–10680 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885–889 (2006). This study shows that the targeted disruption of ATG5 (which blocks autophagy) in neuronal cells results in the formation of inclusion bodies and neurodegeneration. This suggests that normal cellular proteins are autophagy substrates and that a blockade of basal autophagy is neurotoxic.
  Article CAS PubMed Google Scholar
• Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880–884 (2006). This study shows that the targeted disruption of ATG7 (which blocks autophagy) in neuronal cells results in formation of inclusion bodies and neurodegeneration. This study was published together with reference 56, and the two papers provide compelling and complementary evidence that basal autophagy is crucial for neuronal survival.
  Article CAS PubMed Google Scholar
• Yamamoto, A., Lucas, J. J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57–66 (2000).
  Article CAS PubMed Google Scholar
• Ravikumar, B., Berger, Z., Vacher, C., O'Kane, C. J. & Rubinsztein, D. C. Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 15, 1209–1216 (2006).
  Article CAS PubMed Google Scholar
• Kessel, D. & Reiners, J. J. Jr. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett. 18 Oct 2006 (doi:10.1016/j.canlet.2006.09.009).
• Saeki, K. et al. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ. 7, 1263–1269 (2000).
  Article CAS PubMed Google Scholar
• Verhoef, L. G., Lindsten, K., Masucci, M. G. & Dantuma, N. P. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum. Mol. Genet. 11, 2689–2700 (2002).
  Article CAS PubMed Google Scholar
• Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753–766 (2004). This paper provides strong evidence that mycobacteria are degraded by autophagy in infected macrophages.
  Article CAS PubMed Google Scholar
• Nakagawa, I. et al. Autophagy defends cells against invading group A Streptococcus. Science 306, 1037–1040 (2004). This paper shows that autophagy can help to eliminate group A Streptococci in non-phagocytic cells.
  Article CAS PubMed Google Scholar
• Kirkegaard, K., Taylor, M. P. & Jackson, W. T. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nature Rev. Microbiol. 2, 301–314 (2004).
  Article CAS Google Scholar
• Crighton, D. et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126, 121–134 (2006).
  Article CAS PubMed Google Scholar
• Jin, S. p53, autophagy and tumor suppression. Autophagy 1, 171–173 (2005).
  Article CAS PubMed Google Scholar
• Hippert, M. M., O' Toole P, S. & Thorburn, A. Autophagy in cancer: good, bad, or both? Cancer Res. 66, 9349–9351 (2006).
  Article CAS PubMed Google Scholar
• Shintani, T. & Klionsky, D. J. Autophagy in health and disease: a double-edged sword. Science 306, 990–995 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Wienecke, R. et al. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am. J. Kidney Dis. 48, e27–e29 (2006).
  Article PubMed Google Scholar
• Furuya, N., Liang, X. H. & Levine, B. in Autophagy (ed. Klionsky, D. J.) 241–255 (Landes Bioscience, Georgetown, 2004).
  Google Scholar
• Amaravadi, R. K. et al. Autophagy inhibition enhances therapy-induced apoptosis in a _Myc_-induced model of lymphoma. J. Clin. Invest. (2007). This paper suggests that autophagy inhibition enhances various pro-apoptotic chemotherapeutic strategies that might be of value in treating certain cancers.
• Cantley, L. C. & Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl Acad. Sci. USA 96, 4240–4245 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, Z. & Roberts, T. M. Human tumor mutants in the p110α subunit of PI3K. Cell Cycle 5, 675–677 (2006).
  Article CAS PubMed Google Scholar
• Vanhaesebroeck, B., Ali, K., Bilancio, A., Geering, B. & Foukas, L. C. Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem. Sci. 30, 194–204 (2005).
  Article CAS PubMed Google Scholar
• Ward, S. G. & Finan, P. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. Curr. Opin. Pharmacol. 3, 426–434 (2003).
  Article CAS PubMed Google Scholar
• Degenhardt, K. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51–64 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Lum, J. J. et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237–248 (2005). Bax −/− Bak −/− cells activate autophagy, undergo progressive atrophy, and eventually die after growth factor withdrawal. This study shows that autophagy is a protective response against cell death in this context.
  Article CAS PubMed Google Scholar
• Knight, Z. A. et al. A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling. Cell 125, 733–747 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Fan, Q. W. et al. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 9, 341–349 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Hay, N. & Sonenberg, N. Upstream and downstream of mTOR. Genes Dev. 18, 1926–1945 (2004).
  Article CAS PubMed Google Scholar
• Yamamoto, A. et al. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23, 33–42 (1998).
  Article CAS PubMed Google Scholar
• Fass, E., Shvets, E., Degani, I., Hirschberg, K. & Elazar, Z. Microtubules support production of starvation-induced autophagosomes but not their targeting and fusion with lysosomes. J. Biol. Chem. 281, 36303–36316 (2006).
  Article CAS PubMed Google Scholar
• Boya, P. et al. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25, 1025–1040 (2005). This study reports that mammalian cells are much more likely to die after growth factor withdrawal if autophagy is inhibited.
  Article CAS PubMed PubMed Central Google Scholar
• Oltersdorf, T. et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677–681 (2005).
  Article CAS PubMed Google Scholar
• Leung-Toung, R. et al. Thiol proteases: inhibitors and potential therapeutic targets. Curr. Med. Chem. 13, 547–581 (2006).
  Article CAS PubMed Google Scholar
• Kumanomidou, T. et al. The crystal structure of human Atg4b, a processing and de-conjugating enzyme for autophagosome-forming modifiers. J. Mol. Biol. 355, 612–618 (2006).
  Article CAS PubMed Google Scholar
• Knight, Z. A. & Shokat, K. M. Features of selective kinase inhibitors. Chem. Biol. 12, 621–637 (2005).
  Article CAS PubMed Google Scholar
• Levitzki, A. & Gazit, A. Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782–1788 (1995).
  Article CAS PubMed Google Scholar
• Berg, T. Modulation of protein-protein interactions with small organic molecules. Angew. Chem. Int. Ed. Engl. 42, 2462–2481 (2003).
  Article CAS PubMed Google Scholar
• Gestwicki, J. E., Crabtree, G. R. & Graef, I. A. Harnessing chaperones to generate small-molecule inhibitors of amyloid β aggregation. Science 306, 865–869 (2004).
  Article CAS PubMed Google Scholar
• Toogood, P. L. Inhibition of protein–protein association by small molecules: approaches and progress. J. Med. Chem. 45, 1543–1558 (2002).
  Article CAS PubMed Google Scholar